Merck suspends campaign to make Gardasil vaccination mandatory: WSJ

Share this article:
Merck said today it would stop lobbying states to pass laws requiring that preteen girls be vaccinated against cervical cancer, following a growing backlash among parents, healthcare providers and consumer groups, The Wall Street Journal reported. Merck’s aggressive lobbying campaign was intended to bolster sales of its Gardasil vaccine approved last year. The vaccine provides protection against two strains of the human papillomavirus, the virus thought to cause a majority of cervical cancer cases. Merck’s lobbying efforts have become a distraction from the company’s goal of immunizing as many women as possible against cervical cancer said Richard Haupt, Merck’s executive director of medical affairs. Merck has “decided at this point not to lobby for school laws any further,” Haupt told The Journal.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.